Reuters - Merck & Co. on Monday said its second-quarter earnings more than doubled on growing demand for its drugs, blowing past Wall Street expectations, and raised its full-year profit forecast.

Reuters - Merck & Co. Inc. , knocked low by the recall of its arthritis drug Vioxx, is poised to rise because Wall Street has failed to appreciate cost cutting and new products likely to generate bigger-than-expected sales, a report said.

Reuters - Merck & Co. Inc. , knocked low by the recall of its arthritis drug Vioxx, is poised to rise because Wall Street has failed to appreciate cost cutting and new products likely to generate bigger-than-expected sales, a report said.

AP - A federal health official worked with drug maker Merck to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation.

AP - Elaine Doherty was the typical patient to whom drug maker Merck & Co. marketed its former blockbuster painkiller Vioxx: a senior citizen with arthritis and other ailments common among older folks, including heart disease.

A jury on Thursday ruled Merck & Co.'s withdrawn pain medicine Vioxx was not a substantial factor in the heart attack of Elaine Doherty, a 68-year-old New Jersey woman. The jury of five men and two women also decided that although Merck failed to warn the plaintiff Doherty about the heart...

Merck was found not liable in the seventh lawsuit over Vioxx, the arthritis painkiller that it pulled from the market because of heart attack risk, the company announced Thursday.

AP - Merck & Co. won a crucial legal victory on Thursday, when jurors decided that the drugmaker's Vioxx painkiller, now the subject of at least 16,000 product liability lawsuits, did not cause a 68-year-old woman's heart attack.

Reuters - A jury on Thursday found Merck & Co.'s withdrawn pain medicine Vioxx was not a substantial factor in the heart attack of a 68-year-old New Jersey woman.

AP - Jurors in the seventh trial over withdrawn painkiller Vioxx began deliberating Wednesday morning over the plaintiff's claim that the former Merck & Co. drug caused her 2004 heart attack.

AP - Severely clogged arteries, obesity and other factors caused a 68-year-old grandmother's heart attack — not her use of Vioxx, lawyers for the drug's maker told jurors during closing arguments Tuesday in New Jersey's latest case over the withdrawn painkiller.

AP - Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.

AP - Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.

Reuters - All young girls age 11 and 12 should take Merck and Co.'s vaccine to prevent cervical cancer, as should 13- to 26-years-olds if they have not received it already, U.S. advisers decided on Thursday.

AP - A correction published Monday by a medical journal to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people took the drug and did not develop only after 18 months of use as the drug's maker, Merck & Co., has contended.

AP - A correction published Monday to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people were on the drug and did not develop only after 18 months of use as the drug's maker, Merck & Co., has contended.

Zocor, a cholesterol-cutting drug from Merck and Zoloft, antidepressant from Pfizer are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.

AP - The first generic versions of Zocor, the widely used cholesterol drug made by Merck & Co. Inc., received federal approval Friday.

AFP - Merck KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson's disease, after Phase III clinical trials failed.

AFP - Merck KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson's disease, after Phase III clinical trials failed.